Cell-based Viral Vaccines: FDA Issues Final Guidance

Anthrax Vaccine Contract for $78.4 Awarded by HHS

Pneumococcal Disease Vaccine Approved by FDA

Gates Foundation Will Commit $10 Billion for Vaccine Development

Government Commission Calls for Faster Vaccine Production Technologies

Low Vaccination Rates Force Governments to Cancel H1N1 Flu Vaccine Orders

Influenza Vaccine Adjuvant to Improve Effectiveness of Flu Vaccine for Elders

New Joint Venture To Build Asia?s Largest Influenza Vaccine Facility

DNA Vaccine Potential

U.S. Government Funds Vaccine Adjuvant Development

Contact Us

Contact Us

Name

E-mail address


Message